Incidence of chronic atrial fibrillation in general practice and its treatment pattern

Journal of Clinical Epidemiology

Volumn 55, Issue 4, 2002, Pages 358-363

  Ruigómez, Ana ^a   Johansson, Saga ^b,c   Wallander, Mari Ann ^b,d   Rodríguez, Luis Alberto García ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anticoagulation; Atrial fibrillation; Automated database; Epidemiology; Incidence

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DIGOXIN; WARFARIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTICOAGULATION; ARTICLE; AUTOMATION; CARDIOVERSION; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; RISK; VALVULAR HEART DISEASE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; COHORT STUDIES; ELECTRIC COUNTERSHOCK; FAMILY PRACTICE; FEMALE; FIBRINOLYTIC AGENTS; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION;

EID: 0036128687     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00478-4     Document Type: Article

References (28)

1. The epidemiology of atrial fibrillation
2. Epidemiology of atrial fibrillation
3. Atrial fibrillation and atrial flutter
4. Incidence of and risk factors for atrial fibrillation in older adults
5. Atrial fibrillation; epidemiology and the risk and prevention of stroke
6. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
7. Population based study of use of anticoagulants among patients with atrial fibrillation in the community
8. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals
9. Underutilization of antihrombotic therapy in atrial fibrillation
10. Use of the UK General Practice Research Database for pharmacoepidemiology
11. Atrial fibrillation; current knowledge and recommendations for management
12. Use of antithrombotic measures for stroke prevention in atrial fibrillation
13. Prospective cohort study to determine if trial efficacy of antiacoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness
14. Case-control studies; sampling the source population
15. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study
16. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery
17. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation; population-based estimates
18. The natural history of atrial fibrillation; incidence, risk factors, and prognosis in the Manitoba Follow-Up Study
19. A survey of atrial fibrillation in general practice; the West Birmingham Atrial Fibrillation Project
20. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators
21. Epidemiology and significance of atrial fibrillation
22. Atrial fibrillation in the elderly patients; prevalence and comorbidity in general practice
23. Prevalence, age distribution and gender of patients with atrial fibrillation.Analysis and implications
24. Atrial fibrillation, anticoagulation, and stroke
25. Warfarin use following ischemic stroke among medicare patients with atrial fibrillation
26. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation; the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
27. Why do patients with atrial fibrillation not receive warfarin?
28. Atrial fibrillation in the elderly